Vor Biopharma Inc (VOR)

Finanzdaten der Vor Biopharma Inc-Aktie (VOR)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	14.94% 32.33	28.12	35.32	32.17	30.42
Operating Income/Loss	14.94% -32.33	-28.12	-35.32	-32.17	-30.42
Nonoperating Income/Loss	18.30% 1.522	1.863	2.126	2.195	1.989
Income/Loss From Continuing Operations Before Tax	17.30% -30.80	-26.26	-33.19	-29.98	-28.43
Income/Loss From Continuing Operations After Tax	17.30% -30.80	-26.26	-33.19	-29.98	-28.43
Net Income/Loss	17.30% -30.80	-26.26	-33.19	-29.98	-28.43
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	31,078% 68.03	0.2182	67.61	67.03	66.27
Diluted Average Shares	31,078% 68.03	0.2182	67.61	67.03	66.27
Basic Earnings Per Share	18.42% -0.45	-0.38	-0.49	-0.45	-0.43
Diluted Earnings Per Share	18.42% -0.45	-0.38	-0.49	-0.45	-0.43
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-